PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation

Clinical and Translational Oncology

Volumn 14, Issue 3, 2012, Pages 197-206

  Charytonowicz, Elizabeth ^a,b   Matushansky, Igor ^b   Domingo Doménech, Josep ^b   Castillo Martín, Mireia ^b   Ladanyi, Marc ^c   Cordon Cardo, Carlos ^b   Ziman, Mel ^a,d  

^a EDITH COWAN UNIVERSITY   (Australia)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

ARMS; NF kappaB; PAX7 FKHR; PI3K AKT

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYOD1 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FUSION GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MESENCHYMAL STEM CELL; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PAX7 FKHR FUSION GENE; RHABDOMYOSARCOMA; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; MICE; MICROARRAY ANALYSIS; MUSCLE DEVELOPMENT; MYOBLASTS; NF-KAPPA B; ONCOGENE PROTEINS, FUSION; RHABDOMYOSARCOMA, ALVEOLAR; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84860739005     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0784-4     Document Type: Article

References (38)

1. Parham DM, DA Ellison (2006) Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med 130:1454-1465 (Pubitemid 44520712)
2. Barr FG, Qualman SJ, Macris MH et al (2002). Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions. Cancer Res 62:4704-4710
3. Barr FG (2001) Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene 20:5736-5746 (Pubitemid 32928111)
4. Bennicelli JL, Fredericks WJ, Wilson RB et al (1995) Wild type PAX3 protein and the PAX3FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains. Oncogene 11:119-130
5. Cao Y, Wang C (2000) The COOH-terminal transactivation domain plays a key role in regulating the in vitro and in vivo function of Pax3 homeodomain. J Biol Chem 275:9854-9862 (Pubitemid 30185222)
6. Ren YX, Finckenstein FG, Abdueva DA (2008) Mouse mesenchymal stem cells expressing PAXFKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations. Cancer Res 68:6587-6597
7. Torchia EC, Jaishankar S, Baker SJ (2003) Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells. Cancer Res 63: 3464-3468 (Pubitemid 36793021)
8. Riggi N, Cironi L, Suva ML et al (2007) Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET. J Pathol 213:4-20 (Pubitemid 47354561)
9. Riggi N, Suva ML, Stamenkovic I (2009) Ewing's sarcoma origin: from duel to duality. Exp Rev Anticancer Ther 9:1025-1030
10. Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109[Suppl]:S81-96
11. Pacico F, Leonardi A (2006) NF-kappaB in solid tumors. Biochem Pharmacol 72:1142-1152
12. Wang H, Garzon R, Sun H et al (2008) NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14:369-381
13. Bakkar N, Wang J, Ladner KJ et al (2008) IKK/ NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J Cell Biol 180: 787-802 (Pubitemid 351397778)
14. de Alava E, Ladanyi M, Rosai J et al (1995) Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by reverse transcriptase polymerase chain reaction. A speci? c diagnostic assay. Am J Pathol 147:1584-1591
15. Charytonowicz E, Matushansky I, Castillo-Martin M et al (2011) Alternate Pax3 and Pax7 C-terminal isoforms in myogenic differentiation and sarcomagenesis. Clin Trans Oncol 13:194-203
16. Domingo-Domenech J, Pippa R, Tapia M et al (2008) Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells. Breast Cancer Res Treat 112: 53-62
17. Shin JY, Kim JO, Lee SK et al (2010) LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr viruspositive gastric cancer cells. BMC Cancer 10:425
18. Saab R, Bills JL, Miceli AP et al (2006) Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells. Mol Cancer Ther 5:1299-1308 (Pubitemid 43881323)
19. Gang EJ, Bosnakovski D, Simsek T et al (2008) Pax3 activation promotes the differentiation of mesenchymal stem cells toward the myogenic lineage. Exp Cell Res 314:1721-1733
20. Riggi N, Cironi L, Provero P et al (2006) Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. Cancer Res 66: 7016-7023 (Pubitemid 44197677)
21. Barr FG, Nauta LE, Davis RJ et al (1996) In vivo ampli? cation of the PAX3-FKHR and PAX7FKHR fusion genes in alveolar rhabdomyosarcoma. Hum Mol Genet 5:15-21 (Pubitemid 26018269)
22. Baeuerle PA, Baltimore D (1996) NF-kappa B: ten years after. Cell 87:13-20
23. Lee CH, Jeon YT, Kim SH et al (2007) NFkappaB as a potential molecular target for cancer therapy. Biofactors 29:19-35 (Pubitemid 46985299)
24. Meng F, Liu L, Chin PC et al (2002) Akt is a downstream target of NF-kappa B. J Biol Chem 2: 29674-29680
25. Li Y, Jiang B, Ensign WY et al (2000) Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase. Cell Signal 12:751-757 (Pubitemid 32056343)
26. Shoba LN, Newman M, Liu W et al (2001) LY 294002, an inhibitor of phosphatidylinositol 3-kinase, inhibits GH-mediated expression of the IGF-I gene in rat hepatocytes. Endocrinology 142: 3980-3986 (Pubitemid 32802671)
27. Guttridge DC, Mayo MW, Madrid LV et al (2000) NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289:2363-2366
28. Guttridge DC, Albanese C, Reuther JY et al (1999) NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19:5785-5799 (Pubitemid 29339933)
29. Zhang JM, Zhao X, Wei Q et al (1999) Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation. EMBO J 18:6983-6993 (Pubitemid 30000451)
30. Satyanarayana A, Kaldis P (2009) Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 28:2925-2939
31. Zhang JM, Wei Q, Zhao X et al (1999) Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4. EMBO J 18:926-933 (Pubitemid 29082272)
32. Krauss RS (2010) Regulation of promyogenic signal transduction by cell-cell contact and adhesion. Exp Cell Res 316:3042-3049
33. Matushansky I, Hernando E, Socci ND et al (2008) A developmental model of sarcomagenesis de? nes a differentiation-based classi? cation for liposarcomas. Am J Pathol 172:1069-1080 (Pubitemid 351520003)
34. Charytonowicz E, Cordon-Cardo C, Matushansky I et al (2009) Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell? Cancer Lett 279:126-136
35. Tonin PN, Scrable H, Shimada H et al (1991) Muscle-speci? c gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development. Cancer Res 51:5100-5106
36. Schweigerer L, Neufeld G, Mergia A et al (1987) Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors. Proc Natl Acad Sci U S A 84:842-846 (Pubitemid 17033903)
37. Taylor JG, Cheuk AT, Tsang PS et al (2009) Identi? cation of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest 119: 3395-3407
38. Lagha M, Sato T, Bajard L et al (2008) Regulation of skeletal muscle stem cell behavior by Pax3 and Pax7. Cold Spring Harb Symp Quant Biol 73: 307-315